Stock Market Reviews

ALGN (Align Technology, Inc.) News

Get the latest news, insights, and market updates on ALGN (Align Technology, Inc.). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know
  A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.
  Nov 11, 2025 - $ALGN
• A Fresh Look at Align Technology (ALGN) Valuation Following Strong International Growth and Product Innovations
  Align Technology (ALGN) delivered quarterly results that surpassed expectations, fueled by strong international demand and a surge in teen and kids segments. Management also pointed to record global doctor participation and multiple product innovations that are driving momentum. See our latest analysis for Align Technology. Despite ongoing product launches and buyback activity, Align Technology’s share price has yet to recover from its larger declines earlier in the year. The stock has...
  Nov 6, 2025 - $ALGN
• 1 Cash-Heavy Stock to Keep an Eye On and 2 Facing Challenges
  A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
  Nov 5, 2025 - $ALGN
• The Top 5 Analyst Questions From Align Technology’s Q3 Earnings Call
  Align Technology delivered third-quarter results that exceeded Wall Street’s expectations, with international demand for its Clear Aligner products and traction among teens and kids segments playing central roles. Management cited double-digit Clear Aligner volume growth in EMEA and APAC regions, and strong adoption of innovations like the Invisalign Palatal Expander, as key performance drivers. CEO Joe Hogan highlighted that “88,000 doctors globally submitted Invisalign cases, an all-time recor
  Nov 5, 2025 - $ALGN
• Align Technology to Speak at Upcoming Financial Conferences
  TEMPE, Ariz., November 04, 2025--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Te
  Nov 4, 2025 - $ALGN
• Align Technology Opens 2026 Annual Research Program to Advance Orthodontic and Dental Patient Care
  TEMPE, Ariz., November 03, 2025--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its 2026 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to
  Nov 3, 2025 - $ALGN
• CapsoVision Appoints David Garcia as Senior Vice President of Finance
  Seasoned finance executive brings public company, capital markets and transaction experience to support next phase of growthSARATOGA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced the appointment of David Garcia as Senior Vice President of Finance, effective November 3, 2025. Mr. Garcia brings more than 20 years of financial leadership
  Nov 3, 2025 - $ALGN
• Align Technology (ALGN) Margin Decline Tests Bullish Narratives Despite Strong Value and Earnings Forecasts
  Align Technology (ALGN) saw earnings decline by 28.3% per year over the past five years, with its net profit margin dropping to 9.5% from 11.1% the year before. Despite this, the company is expected to turn a corner, as projections call for EPS growth of 18.1% per year and revenue growth of 4.8% per year. However, that revenue pace trails the US market’s 10.3% average. The latest results show tighter margins, but upbeat forecasts and a strong history of quality earnings could help underpin...
  Oct 31, 2025 - $ALGN
• ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash
  Align Technology jumps 15% after Q3 earnings and revenues beat estimates, though steep margin declines weigh on results.
  Oct 30, 2025 - $ALGN
• ALGN Q3 Deep Dive: International Aligner Growth and New Technology Offset U.S. Dental Headwinds
  Dental technology company Align Technology (NASDAQ:ALGN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 1.8% year on year to $995.7 million. The company expects next quarter’s revenue to be around $1.04 billion, close to analysts’ estimates. Its non-GAAP profit of $2.61 per share was 8.4% above analysts’ consensus estimates.
  Oct 30, 2025 - $ALGN